小鼠模型市场规模、份额及成长分析（依模型类型、技术、应用、最终用户及地区划分）－2025-2032年产业预测

预计到 2023 年，全球小鼠模型市场规模将达到 16 亿美元，到 2024 年将达到 17.1 亿美元，到 2032 年将达到 28.4 亿美元，预测期（2025-2032 年）的复合年增长率为 6.6%。

全球小鼠模型市场受到癌症、糖尿病和心血管疾病等慢性疾病发生率上升的显着影响，促使医疗保健系统优先考虑早期诊断和治疗方法创新。由于小鼠在遗传、生物学和行为学方面与人类具有相似性，製药和生物技术公司越来越多地利用小鼠作为重要的临床前测试模型，这有助于了解疾病进展并评估治疗方法。慢性疾病盛行率的快速成长推动了研发领域的巨额投资，从而导致对先进小鼠模型的需求不断增长，以促进药物发现。此外，基因工程技术的快速发展，特别是CRISPR-Cas9技术的进步，正在透过实现基因改造和人源化模型的精确构建，改变这一领域，提高了临床前试验的准确性，并加速了治疗方法进展。

全球小鼠模型市场驱动因素

慢性疾病（包括癌症、糖尿病和心血管疾病）的日益流行，正显着推动全球小鼠模型市场的成长。小鼠模型在阐明疾病机制和评估潜在治疗性介入方面发挥关键作用。它们在加速药物研发方面的重要性不容忽视，因为研究人员越来越依赖这些模型来创新和开发有效的治疗方法。对先进治疗方法的日益增长的需求凸显了生物医学研究领域对小鼠模型的必要性，从而推动旨在改善患者预后和应对与慢性疾病相关的紧迫医疗保健挑战的进展。

全球小鼠模型市场限制因素

全球小鼠模型市场面临许多挑战，主要源自于实验室小鼠的繁殖、饲养和圈养成本高。对专业设施的需求、对专业人员的聘用以及对严格伦理标准的遵守，都显着增加了营运成本。这些经济壁垒限制了小型研究机构的进入，使其难以有效参与市场。此外，这些限制在资源本就有限的发展中地区尤其严重。因此，整体市场成长受到阻碍，使得众多机构难以为研发进步做出贡献。

全球小鼠模型市场趋势

全球小鼠模型市场正呈现显着趋势，製药和生物技术公司越来越多地采用人源化和基因转殖小鼠模型。这些先进的模型能够更精确地模拟人类疾病状态，从而提高临床前试验的预测准确性。随着企业寻求加速药物研发进程并降低临床试验失败率，这些先进小鼠模型的需求持续成长。这种转变不仅推动了产业创新，也为更有效的治疗性介入铺平了道路，巩固了先进小鼠模型在生物医学研究中的关键作用。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

依型号类型分類的滑鼠模型市场规模及复合年增长率（2025-2032 年）

• 市场概览
• 近交系小鼠
• 非近交系小鼠
• 基因转殖小鼠（GEM）
• 杂交/共基因小鼠

按技术分類的小鼠模型市场规模及复合年增长率（2025-2032 年）

• 市场概览
• CRISPR/基因编辑
• 胚胎干细胞注射
• 显微注射/核移植
• 常规育种和再诱导

按应用领域分類的滑鼠模型市场规模及复合年增长率（2025-2032 年）

• 市场概览
• 药物发现与开发
• 疾病模式（肿瘤学、免疫学、神经病学、代谢学）
• 毒理学与安全药理学
• 个人化医疗/转化研究

依最终使用者分類的滑鼠市场规模及复合年增长率（2025-2032 年）

• 市场概览
• 製药和生物技术公司
• 学术和研究机构
• 受託研究机构（CRO）
• 政府和监管机构

小鼠模型市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences
• Envigo
• Janvier Labs
• GenOway
• Cyagen Biosciences
• BioCytogen
• InVivo Biosystems
• Ozgene
• Horizon Discovery
• Crown Bioscience
• The Jackson Laboratory for Genomic Medicine
• GenOway SA
• Transgenic Animal Model Technologies（TAMT）
• Wuxi AppTec
• LAB Research Models & Services
• Biocytogen Pharma Technology
• GeneChem Co., Ltd.
• Shanghai Model Organism Center

结论与建议

Global Mice Model Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.71 billion in 2024 to USD 2.84 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2025-2032).

The Global Mice Model Market is significantly influenced by the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions, prompting healthcare systems to emphasize early diagnosis and therapeutic innovations. Pharmaceutical and biotech companies increasingly utilize mice as essential preclinical testing models due to their genetic, biological, and behavioral parallels with humans, thereby enhancing the understanding of disease progression and therapy evaluation. This surge in chronic disease prevalence drives substantial research and development investments, subsequently increasing the demand for sophisticated mice models to facilitate drug discovery. Additionally, the rapid evolution of genetic engineering techniques, particularly CRISPR-Cas9, is transforming the sector by enabling precise creation of transgenic and humanized models, subsequently enhancing the accuracy of preclinical studies and expediting therapeutic advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mice Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mice Model Market Segments Analysis

Global Mice Model Market is segmented by Model Type, Technology, Application, End-User and region. Based on Model Type, the market is segmented into Inbred Mice, Outbred Mice, Genetically Engineered Mice (GEM) and Hybrid / Congenic Mice. Based on Technology, the market is segmented into CRISPR / Gene-Editing, Embryonic Stem Cell Injection, Microinjection / Nuclear Transfer and Traditional Breeding & Rederivation. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling (Oncology, Immunology, Neurology, Metabolic), Toxicology & Safety Pharmacology and Personalized / Translational Research. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations (CROs) and Government & Regulatory Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mice Model Market

The rising prevalence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases, significantly propels the growth of the global mice model market. Mice models play a pivotal role in understanding disease mechanisms and assessing potential therapeutic interventions. Their importance in facilitating drug discovery cannot be overstated, as researchers increasingly rely on these models to innovate and develop effective treatments. This escalating demand for advanced therapies underscores the necessity of mice models in the biomedical research landscape, driving advancements that aim to improve patient outcomes and address the urgent healthcare challenges associated with chronic diseases.

Restraints in the Global Mice Model Market

The global Mice Model market encounters several challenges primarily due to the substantial costs linked to the breeding, upkeep, and housing of laboratory mice. The need for specialized facilities, the employment of skilled personnel, and adherence to strict ethical standards considerably elevate operational expenses. These financial barriers can restrict access for smaller research institutions, hindering their ability to participate effectively in this market. Additionally, these constraints disproportionately impact developing regions, where resources are already limited. As a result, the overall growth of the market is stymied, making it difficult for a wide range of institutions to contribute to advancements in research and development.

Market Trends of the Global Mice Model Market

The Global Mice Model market is experiencing a significant trend towards the increased adoption of humanized and transgenic mice models among pharmaceutical and biotech companies. These advanced models offer enhanced capabilities for accurately simulating human disease conditions, which in turn improves the predictive value of preclinical studies. As companies aim to expedite drug discovery processes and minimize failure rates during clinical trials, the demand for these sophisticated mice models continues to grow. This shift not only fuels innovation within the industry but also establishes a pathway for more effective therapeutic interventions, solidifying the essential role of advanced mice models in biomedical research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Mice Model Market Size by Model Type & CAGR (2025-2032)

• Market Overview
• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice (GEM)
• Hybrid / Congenic Mice

Global Mice Model Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CRISPR / Gene-Editing
• Embryonic Stem Cell Injection
• Microinjection / Nuclear Transfer
• Traditional Breeding & Rederivation

Global Mice Model Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Disease Modeling (Oncology, Immunology, Neurology, Metabolic)
• Toxicology & Safety Pharmacology
• Personalized / Translational Research

Global Mice Model Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organisations (CROs)
• Government & Regulatory Agencies

Global Mice Model Market Size & CAGR (2025-2032)

• North America (Model Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (Model Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Model Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Model Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Model Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taconic Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envigo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janvier Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenOway
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCytogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InVivo Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ozgene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory for Genomic Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenOway SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transgenic Animal Model Technologies (TAMT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LAB Research Models & Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Pharma Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneChem Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Model Organism Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations